BRIEF-Rxi Pharmaceuticals Says $4.9 Mln Registered Direct Offering Priced At-The Market

April 9 (Reuters) - Rxi Pharmaceuticals Corp:

* RXI PHARMACEUTICALS ANNOUNCES $4.9 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* ENTERED AGREEMENTS FOR PURCHASE OF 1.5 MLN SHARES AT $3.24375/SHARE IN REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* TO USE PROCEEDS FROM OFFERING TO FUND PRECLINICAL & CLINICAL DEVELOPMENT, OTHER RESEARCH & DEVELOPMENT ACTIVITIES, AMONG OTHERS Source text for Eikon: Further company coverage: